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Abstract
Background:  Although the effects of resistant starch (RS) on postprandial glycemia and
insulinemia have been extensively studied, little is known about the impact of RS on fat metabolism.
This study examines the relationship between the RS content of a meal and postprandial/post-
absorbative fat oxidation.
Results: 12 subjects consumed meals containing 0%, 2.7%, 5.4%, and 10.7% RS (as a percentage of
total carbohydrate). Blood samples were taken and analyzed for glucose, insulin, triacylglycerol
(TAG) and free fatty acid (FFA) concentrations. Respiratory quotient was measured hourly. The
0%, 5.4%, and 10.7% meals contained 50 µCi [1-14C]-triolein with breath samples collected hourly
following the meal, and gluteal fat biopsies obtained at 0 and 24 h. RS, regardless of dose, had no
effect on fasting or postprandial insulin, glucose, FFA or TAG concentration, nor on meal fat
storage. However, data from indirect calorimetry and oxidation of [1-14C]-triolein to 14CO2
showed that addition of 5.4% RS to the diet significantly increased fat oxidation. In fact, postprandial
oxidation of [1-14C]-triolein was 23% greater with the 5.4% RS meal than the 0% meal (p = 0.0062).
Conclusions: These data indicate that replacement of 5.4% of total dietary carbohydrate with RS
significantly increased post-prandial lipid oxidation and therefore could decrease fat accumulation
in the long-term.
Background
Resistant starch (RS) is any starch that is not digested in
the small intestine but passes to the large bowel for fer-
mentation [1]. Retrograded amylose (a linear polymer of
glucose residues linked by α(1→4) bonds; RS1), such as
cooked and cooled starchy foods like pasta salad, and
native starch granules (RS2), such as those found in high-
amylose maize starch and bananas, are the major compo-
nents of dietary RS. Calories from RS that are undigested
in the small intestine can be salvaged by fermentation to
short-chain fatty acids (SCFA; acetate, butyrate, proprion-
ate) by the microflora of the large bowel. Fermentation of
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RS in the large bowel gives rise to increased production of
SCFA which is reflected in higher epithelial and portal
concentrations. SCFA concentration in the periphery,
however, is very low and therefore difficult to measure
accurately so any increase in production of SCFA in
response to RS consumption may not be detectable in the
peripheral circulation.
Acute human studies describe variable postprandial glyc-
emic and/or insulinemic responses to RS ingestion. In
general, it is accepted that RS consumption lowers post-
prandial glucose concentrations marginally and postpran-
dial insulin concentrations markedly. Many groups report
a decrease in postprandial glycemic or insulinemic
responses to RS ingestion relative to digestible starch (DS)
consumption [2-7], whereas some report no change [8-
11]. It is important to note that the fat content of the diet
has a significant impact on the glycemic response to a
meal and some meal tests contained no fat or the fat con-
tent of the meal varied among the different RS diets mak-
ing results from these studies difficult to interpret [2-4].
Also, there are many sources of RS, such as beans, high
amylose corn starch, and potatoes, which possess differ-
ent physicochemical properties. So, the source of RS can
influence the glycemic/insulinemic response to RS
ingestion.
Many studies have examined the relationship between RS
ingestion and postprandial metabolite and hormone con-
centrations. Fewer studies have documented the effect of
RS on lipid metabolism. In humans, five weeks of RS feed-
ing lowered fasting cholesterol and triglyceride concentra-
tions and postprandial plasma insulin concentrations
relative to digestible starch (DS) feeding [12,13]. It has
also been reported that chronic RS feeding in rats causes a
decrease in adipocyte cell size relative to DS feeding
[14,15]. In addition, expression of fatty acid synthase was
lower in rats fed a RS-based diet than in those fed a DS-
based diet [16]. Taken together, these studies provide evi-
dence that RS intake has an effect upon the activity of key
lipogenic enzymes and adipocyte morphology. Thus, it
seems that the effects of this carbohydrate subtype on
lipid metabolism should be carefully examined in human
studies.
It is possible that strong physical association between RS
and dietary lipid may slow the absorption, and thereby
increase the oxidation, of dietary lipid. Currently, there is
no evidence pertaining to the dose-response relationship
for RS ingestion (as part of a mixed meal) and postpran-
dial glycemia, insulinemia, fat oxidation, or meal fat stor-
age. It is important that these parameters be defined
before designing and conducting long-term, prospective
RS feeding studies.
Results
No difference in fasting or postprandial insulin, glucose,
FFA, or triglyceride concentration was observed between
any of the RS doses examined (Figure 1).
Overall, the dose of RS in the meal had a significant influ-
ence on ∆RQ (respiratory quotient) values (F-test, 0.04;
Figure 2). This overall effect was due to a significantly
lower ∆RQ at the 5.4% RS dose than the 0% (p = 0.02) or
10.7% (p = 0.009) RS doses, indicating an increase in fat
oxidation in response to the 5.4% RS meal relative to the
0% and 10.7% RS doses (Figure 2). ∆RQ was significantly
lower for the 5.4% RS meal than 0% RS meal at 120, 240,
300 and 360 minutes (p = 0.05, 0.03, 0.02 and 0.04,
respectively) whereas significant differences occurred at
120, 180, 240, 300 and 360 minutes (p = 0.01, 0.01,
0.005, 0.02, and 0.03, respectively) for the 5.4% RS versus
10.7% RS meals. These data are reflected in total macro-
nutrient oxidation rates (Figure 3), which show a signifi-
cant increase in the amount of fat oxidized at the 5.4% RS
dose relative to the 0% RS meal, with a concomitant
decrease in total carbohydrate oxidation.
Similarly, the oxidation of [14C]-triolein to 14CO2 was dif-
ferent between RS doses (F-test, 0.0005). Meal fat oxida-
tion at the 5.4% RS dose was significantly higher than
both the 0% (p = 0.0062) and 10.7% doses (p < 0.0001).
Separate tests at 6 h or 24 h following the test meal gave
comparable results (Figure 4a). Taken together, these
independent measurements of fat oxidation (indirect
calorimetry, oxidation of [14C]-triolein to 14CO2) suggest
that the inclusion of 5.4% RS in the meal elevated post-
prandial fat oxidation. Unexpectedly, this effect was lost if
the dose was increased to 10.7% RS.
There was a trend for fat storage from the test meal, as
assessed by incorporation of 14C into gluteal adipose tis-
sue, to be lower for the 5.4% RS meal than all other meals,
although this effect did not reach statistical significance
(Figure 4b).
Discussion
This study demonstrated that the addition of RS to a
mixed meal, balanced for total fat and fiber content, had
no effect on postprandial glucose, insulin, FFA, or triglyc-
eride excursions. However, meals containing a moderate
amount of RS caused an increase in fat oxidation as meas-
ured by both indirect calorimetry and the production of
14CO2 from a 14C-triglyceride tracer. Unexpectedly, the
dose-response relationship between RS content of the diet
and fat oxidation was not linear. Although this result is
difficult to explain in the current context, it emphasizes
the need for careful selection of RS dose in prospective
feeding studies.Nutrition & Metabolism 2004, 1:8 http://www.nutritionandmetabolism.com/content/1/1/8
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Circulating glucose (a, b), insulin (c, d), free fatty acid (e), and triglyceride (f) concentrations in response to the RS content of a  breakfast meal Figure 1
Circulating glucose (a, b), insulin (c, d), free fatty acid (e), and triglyceride (f) concentrations in response to the 
RS content of a breakfast meal. Serum glucose and insulin measurements were conducted on 12 healthy adults. Data is 
presented as mean ± SEM.
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There was no difference in postprandial glucose (Figure
1a), FFA (Figure 1e), triglyceride (Figure 1f), or insulin
(Figure 1c) concentrations at any RS dose examined. This
concurs with data from other acute human studies using
complete, mixed meals which showed no difference in
postprandial glycemia/insulinemia in response to RS con-
tent of the diet [8-11]. Although this seems contrary to the
general perception that RS ingestion reduces postprandial
insulinemia and glycemia, many of the studies indicating
this did not balance test diets for total fat and/or fiber con-
tent [17]. However, in the current study all diets were care-
fully matched for total fat and fiber content. This an
important distinction between this and other studies as
fiber has extensively been shown to reduce postprandial
glycemia/insulinemia and increasing the RS content of the
diet intrinsically increases the total fiber content. Also,
dietary fat can have potent effects on the accessibility of
dietary carbohydrate to digestive enzymes and on the rate
of gastric emptying/gut motility. Thus, the glucose- and
insulin-lowering effects of RS that have been observed in
other studies may be due to changes in fiber and/or fat
between test meals which have been extensively shown to
lower postprandial glycemic and insulinemic responses.
So, the balanced conditions used in the meal tests for the
study described herein, which included baked products
and processed foods as part of a complete, mixed meal,
balanced for total fat and fiber content, could account for
the lack of difference in insulinemia and glycemia in
response to increased RS content in the diet.
Both indirect calorimetry and 14C-tracer data indicate that
there was an increase in fat oxidation between the 0% and
5.4% RS doses (Figures 2, 3, and 4a). This increase in total
and meal fat oxidation in response to the 5.4% RS meal is
not driven by disparate responses amongst subjects as 11
of the 12 subjects studied showed the greatest fat oxida-
tion in response to the 5.4% RS meal, relative to the 0%
and 10.7% RS meals (see Figure S1, Additional File 1, for
individual responses). Tracer data showed that the addi-
tion of 5.4% of RS to a meal increased meal fat oxidation
by more than 20% over the 6 h and 24 h post-meal inges-
tion period (Figure 4a). The increase in fat oxidation at 6
h accounted for approximately one-half of the total
increase over 24 h, indicating that the increase in meal fat
oxidation in response to a single meal containing 5.4% RS
is a prolonged, sustained effect. In addition, comparison
of total and meal fat oxidation (Figures 3a and 4a) indi-
cates that endogenous fat stores were the predominant
source of fat utilized for energy, contributing approxi-
mately 80% of the total fat oxidized, with a much lower
contribution from ingested meal fat. Figure 3 shows that
this increase in fat oxidation at the 5.4% RS dose is accom-
panied by a relative reduction in carbohydrate oxidation
(does not reach statistical significance).
The increase in fat oxidation at the 5.4% RS dose relative
to the 0% dose was not driven by any disparity in circulat-
ing glucose, insulin or FFA concentration (Figure 1; see
Figures S2, S3, S4, Additional Files 2, 3, 4, respectively, for
individual subject responses) nor by a difference in avail-
able carbohydrate between the 0% and 5.4% RS meals. If
decreased carbohydrate availability was responsible for
the observed increase in fat oxidation, the 10.7% RS meal,
which has the least available carbohydrate, would show
the greatest increase in fat oxidation. However, there was
no difference in fat oxidation between the 0% and 10.7%
RS meals. Thus, carbohydrate availability cannot be a con-
tributing factor to the increase in fat oxidation observed at
the 5.4% dose of RS. It is possible that this increase may
be due to an increase in circulating SCFAs from the fer-
mentation of RS reaching the large bowel. The observed
increase in fat oxidation is not due to oxidation of these
SCFAs per se as it was measured directly from conversion
of 14C-labeled meal fat to 14CO2 (Figure 3a). Such a meas-
urement would not detect any increase in SCFA oxidation.
Rather, it may be that the metabolic effects of increased
SCFA production cause an increase in fat oxidation.
Respiratory quotient (RQ; change from baseline) in response  to RS content of a breakfast meal Figure 2
Respiratory quotient (RQ; change from baseline) in 
response to RS content of a breakfast meal. Respira-
tory gas exchange measurements were conducted on 12 
healthy adults using the ventilated hood method. Data is pre-
sented as mean ± SEM. * p < 0.05 for a difference from the 
0% meal at the same time point. # p < 0.03 for a difference 
with the 10.7% meal at the same time point.
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RS consumption has been shown to alter the ace-
tate:butyrate:propionate ratio compared to fermentation
of non-starch polysaccharides [29]. In particular, the
amount of butyrate is substantially elevated in response to
RS fermentation [30,31]. In humans fed a low or high RS
diet for three days, the concentration of excreted SCFA
rose from 20 mmol/d to 33 mmol/d, respectively [19].
This increase in total SCFA concentration was caused by a
doubling of the acetate and butyrate content changing the
acetate:butyrate:propionate ratio from 12:3:3 to 21:6:4 in
response to the low and high RS diets, respectively.
In vitro data from isolated animal tissues provide convinc-
ing evidence for the role of SCFAs in carbohydrate and
lipid metabolism [26,32-34]. Acetate and/or butyrate
have been shown to decrease glycogenolysis and glycoly-
sis in isolated rat and sheep hepatocytes [35-37]. So, it is
plausible that the fermentation of RS from the 5.4% RS
diet increases the net production of SCFAs which inhibit
glycolysis in the liver. In this scenario, the liver, deprived
of carbohydrate-derived acetyl CoA would be more reliant
on fat-derived acetyl CoA as a fuel source, thereby contrib-
uting to an overall increase in fat oxidation [17]. This pos-
sibility needs to be investigated in future studies.
No difference in fat oxidation was evident between the
maximal 10.7% dose of RS and the 0% dose. This is an
unexpected result that is difficult to explain. The loss of
any effect on fat oxidation when the RS dose in the meal
was increased to 10.7% may occur because this dose is at
the threshold of the starch's properties as RS. That is, at the
10.7% dose of RS, the starch may not be completely fer-
mented in the large bowel thereby causing a loss of energy
from the diet via the feces. If this is the case, the strong
physical association between RS and dietary lipid may
cause excretion of lipid and therefore, less dietary fat to be
available for oxidation at the 10.7% dose. Indeed, it has
previously been shown that intake of high-amylose maize
starch, such as that used in this study, caused an increased
number of bowel actions per day [18]. RS has also been
shown to decrease colonic transit time and, as more RS
enters the large bowel, more starch is also excreted
[19,20]. This indicates that, at higher levels of RS con-
sumption, only a portion of the RS can be fermented and
the remainder passes through the colon as an insoluble
fiber. Furthermore, if indeed RS at the 10.7% dose is being
excreted as insoluble fiber, less fermentation and SCFA
production would be occurring. As SCFA are hypothesized
to be the cause of the observed increase in fat oxidation in
Total fat (a) and carbohydrate (b) oxidation in response to RS content of a breakfast meal Figure 3
Total fat (a) and carbohydrate (b) oxidation in response to RS content of a breakfast meal. Macronutrient oxida-
tion, assessed via indirect calorimetry and calculated from non-protein RQ, was measured in 12 healthy adults. Data is pre-
sented as mean ± SEM. * p ≤ 0.003 for a difference from the 0% and 10.7% RS meals.
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response to the 5.4% RS meal, this would have a large
impact on the fat oxidation potential of the 10.7% RS diet.
The hypothesis that RS is acting like dietary fiber and
being excreted can be tested by measuring the amount of
fat excreted in the feces. As this outcome was not pre-
dicted, fecal samples were not collected from subjects dur-
ing this study. It is important to consider that it is difficult
to add 10.7% RS to a standard diet without the use of spe-
cially designed foods and/or without significantly increas-
ing caloric intake. Therefore, this level would be difficult
to attain in a free-living situation and the lower doses used
in this study are more reflective of predicted levels if nor-
mal, starchy foods in the diet were to be replaced with
commercially available RS products.
In addition, not all biological processes display linear
dose-response curves. Dose-response curves can vary from
sigmoidal to 'U'-shaped curves for processes as diverse as
drug absorption/clearance [21], low dose radiation effects
on cells [22], DNA repair following double-strand breaks
[23], and metabolic parameters. Metabolic processes that
are non-linear functions include the level of illuminance
and plasma melatonin levels [24], caffeine intake versus
plasma caffeine metabolite concentrations [25], allergen
exposure (concentration) and histamine response [26],
zinc-stimulated histamine release from mast cells [27],
and fructose-1,6-diphosphate metabolism in cardiomyo-
cytes [28]. Thus, it is possible that the lack of any effect on
fat oxidation at the 10.7% RS dose may indicate that the
relationship between RS intake and fat oxidation is indeed
a 'U'-shaped curve. However, more RS doses between
5.4% and 12% must be tested to accurately define the
shape of this dose response curve.
It must be noted that the calculation of oxidation of [14C]-
triolein via measurement of 14CO2  did not take into
account the dilution of tracer in vivo due to the incorpora-
tion of labeled carbons into intermediates of the TCA
cycle and endogenous bicarbonate pools. Generally, an
acetate correction factor is used to account for this effect.
In this study, subjects consumed all four test meals under
Meal fat oxidation (a) and storage (b) in response to RS content of a breakfast meal Figure 4
Meal fat oxidation (a) and storage (b) in response to RS content of a breakfast meal. Meal fat oxidation, assessed 
via measurement of 14CO2 in expired air, and meal fat storage in gluteal adipose tissue was measured in 12 healthy adults. Data 
is presented as mean ± SEM. * p ≤ 0.0006 for a difference from the 0% and 10.7% RS meals at the same time point. FFM, fat free 
mass.
b)  Meal fat storage 
M
e
a
l
 
f
a
t
 
s
t
o
r
e
d
 
(
g
/
2
4
h
/
w
h
o
l
e
 
b
o
d
y
)
0 5.4 10.7
RS content of meal (%)
a) Meal fat oxidation
RS content of meal (%)
M
e
a
l
 
f
a
t
 
o
x
i
d
a
t
i
o
n
 
(
g
 
o
x
i
d
i
z
e
d
/
g
 
F
F
M
)
0
1
2
3
4
5
0.00
0.01
0.02
0.03
0.04
0.05
0.06
24 h
6 h
*
*
0 5.4 10.7Nutrition & Metabolism 2004, 1:8 http://www.nutritionandmetabolism.com/content/1/1/8
Page 7 of 11
(page number not for citation purposes)
the same conditions and it was assumed that there was no
difference in tracer recovery between tests. Also, these TCA
intermediate and bicarbonate pools were not pre-labeled
prior to the ingestion of the label in the meal which would
cause a total underestimation of total fat oxidation. There-
fore, the rate of fat oxidation calculated from 14CO2 recov-
ery in the breath was probably underestimated in all
subjects but remains valid to compare differences between
test meals.
There was a trend towards a decrease in gluteal fat storage
at the 5.4% RS dose relative to all other doses (Figure 4b).
Again, the dose-response curve for this parameter was not
linear, lending credence to the idea that the dose-response
curve for fat oxidation is actually U-shaped. Although the
decrease in fat storage at the 5.4% RS dose did not reach
statistical significance, it is intuitive that, given the magni-
tude of the increase in fat oxidation observed at this dose,
there would be a reciprocal decrease in fat storage. How-
ever, there was high variability associated with the meas-
ure of meal fat storage indicating that more subjects may
be needed to decrease the standard deviation and, hence,
detect any significant meal affect.
Conclusion
This study is the first to identify that addition of 5.4% RS
to a single meal can cause a significant increase in total
and meal fat oxidation in healthy individuals relative to a
0% RS diet over the postprandial/postabsorptive period
(24 h). This discovery was verified using two different
methods, indirect calorimetry and the oxidation of [14C]-
triolein to 14CO2, to measure in vivo fat oxidation. This
increase in fat oxidation was accompanied by a concomi-
tant decrease in carbohydrate oxidation and fat storage,
although these parameters did not reach statistical signif-
icance. Further, the magnitude of the increase in fat oxida-
tion indicates that this effect is biologically relevant and
could be important for preventing fat accumulation in the
long term by effecting total fat balance under chronic
feeding conditions. Finally, this study revealed that there
may be a maximal effect of RS addition to the diet and
that the addition of RS over this threshold confers no met-
abolic benefit or change from a 0% RS meal.
Methods
Subjects
12 healthy adults, 7 male and 5 female, participated in the
present study. This study was approved by the Colorado
Multiple Institution Review Board, in compliance with
the Helsinki Declaration, and full written consent was
obtained from all subjects. To participate, subjects were
required to be between 28 and 45 years of age, have nor-
mal glucose tolerance (as judged via response to an oral
glucose tolerance test; fasting glucose concentration < 6
mM, postprandial glucose concentration not higher than
9 mM), moderate level of physical activity (no more than
4 one-hour bouts of planned physical activity per week),
and a BMI between 20 and 28. All female subjects were
taking oral contraceptive pills or progesterone injections
and were tested during the early follicular phase of the
menstrual cycle. All subjects underwent dual energy X-ray
absorptiometry (DEXA; Lunar Radiation Corp, Madison
WI) for analysis of body composition. As a group, subjects
were 33 ± 5 years of age, 1.7 ± 0.07 m tall, weighed 75 ±
11 kg, had a BMI of 24.7 ± 2.4, total fat mass of 18.3 ± 5.0
kg (mean ± SD), and a fasting RQ of 0.750 ± 0.023 (mean
± SEM).
Diet
Subjects received four meals differing only in resistant
starch (RS) content in random order, approximately four
weeks apart. Test meals contained either 0%, 2.7%, 5.4%,
or 10.7% RS as a percentage of total dietary carbohydrate.
All added RS was in the form of high-amylose maize
starch, or RS2. High-amylose maize starch was chosen as
it has the unique property of a very high gelatinisation
temperature which allows it to maintain its granular struc-
ture during and after the processing conditions used to
manufacture the foods being consumed in this study [38].
All meals were isocaloric, accounting for 30% of the sub-
ject's daily energy needs as measured by indirect calorim-
etry prior to study commencement (RMR × daily activity
factor of 1.49). The composition of the test diet was 55%
carbohydrate, 15% protein, and 30% fat as a percentage of
total energy (Table 1). All meals were matched for total
dietary fiber content and liquid volume (250 ml).
Three days prior to each test day, subjects received a stand-
ardized lead-in diet, equivalent to daily energy needs as
judged by indirect calorimetry and of the same macronu-
trient composition as the test diet with no added RS, to
ensure that they were in energy balance. All food for these
three days was provided by the General Clinical Research
Center (GCRC) on an outpatient basis. Subjects were
instructed to eat all of the food/drink provided and not to
consume any other foods. Non-caloric beverages could be
consumed during the three day lead-in diet.
Protocol
Following an overnight fast (12 h), subjects were admitted
to the GCRC and an intravenous catheter was placed for
the purposes of drawing blood. The test meal began at 0
min (0800 h) with all food/drink fully consumed within
15 min. Blood samples were taken at 0, 30, 60, 90, 120,
180, 240, 300, and 360 min following meal ingestion and
analyzed for glucose, insulin, triacylglycerol (TAG) and
free fatty acid (FFA) concentrations. Respiratory quotient
(RQ) was measured at hourly intervals after ingestion of
the meal via gas collection under a ventilated plexiglassNutrition & Metabolism 2004, 1:8 http://www.nutritionandmetabolism.com/content/1/1/8
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hood for 15 min (Sensormedics 2900 metabolic cart). All
urine produced between 0 and 360 min was collected and
analyzed for nitrogen content by the GCRC Core Labora-
tory to facilitate calculation of non-protein RQ.
In three of the test meals (0%, 5.4%, and 10.7% RS
meals), the bread product in the test meal was spiked with
50 µCi [1-14C]-triolein (glycerol tri [1-14C]oleate; Amer-
sham Pharmacia Biotech, Amersham, UK) suspended in
olive oil and the tests were conducted as 24 h inpatient
stays at the GCRC. The fat tracer was fed as a triglyceride
(glycerol tri [1-14C]oleate) rather than a FFA (eg. [1-
14C]oleate) in order to reflect any change in the absorp-
tion of triglyceride FFA which might be due to a strong
physical association with RS thereby slowing absorption.
At hourly intervals following the meal, then at 8, 10, 12,
14 and 24 hours, breath samples were collected via exha-
lation through a tube with a one-way valve into scintilla-
tion vials containing 2 mmol benzethonium hydroxide
(to trap 2 mmol CO2), 1 ml methanol, and 1 mg phenolp-
thalene as a pH indicator. Gluteal fat biopsies were col-
lected by aspiration through a 14 g stainless steel needle at
baseline and 24 h after ingestion of the test meal. All
breath and fat samples were assayed for the presence of
14C (as described below). For these 24 h tests, subjects
received 30% of daily energy needs at each of breakfast,
lunch, and dinner, with the remaining 10% of calories
received in an evening snack. The timing of meals/snacks
was kept constant over all tests. All food was provided by
the GCRC on an inpatient basis and the macronutrient
content of each meal was the same as that of the test meal.
Only the test breakfast contained RS during these 24 h
tests, all other meals were composed of standard, com-
mercially available products.
Analyses
All glucose, FFA, and TAG assays were conducted by the
GCRC Core Laboratory using an automated Cobas Mira
Plus (Roche Diagnostics, Basel, Switzerland). Serum insu-
lin measurements were also performed by the GCRC Core
Laboratory using a human insulin RIA kit (Linco, St.
Louis, USA).
Fat samples, frozen in liquid nitrogen and stored at -80°C
until processing, were incubated in 450 µl Solvable (Pack-
ard Bioscience, Groningen, Netherlands) at 50°C for 12 h
Table 1: Composition of test breakfasts. All values are based on a hypothetical subject who requires 8374 kJ (2000 kcal) per day.
RS content (% total carbohydrate) 0 2.7 5.4 10.7
RS content (g)1 0  g2 . 5  g 5  g1 0  g
Total energy (kJ) 2508 2506 2500 2506
Carbohydrate (g) 93.8 93.3 92.9 93.0
Protein (g) 22.7 22.6 23.0 23.0
Fat (g) 17.0 16.8 16.9 16.9
Total sugars (g) 45.6 45.2 45.7 45.1
Total Fiber (g) 9.4 9.3 9.5 9.5
Liquid volume (mL) 250 250 250 250
Foods consumed (g)
Canned spaghetti 197 58
*RS Canned spaghetti 147 218 216
Parmesan cheese 10 8 8 12
Margarine 4 3 2 2
Butter 2 1 1
Milk (2% fat) 250 250 210
*Up & Go breakfast drink 40 250
Bread 38 44 36
*Banana muffin 43
Strawberries 203 162 123
Grapes 80 93
*Fruit fingers 15 16
Sugar, white 10
* Denotes foods with added RS.
1 Absolute RS inclusion varied according to the energy needs of the subject so that RS content always remained the same fraction of total dietary 
carbohydrate, namely 0%, 2.7%, 5.4%, and 10.7% for the 0 g, 2.5 g, 5 g, and 10 g meals, respectively. For example, a subject who had a daily caloric 
need of 9421 kJ (2250 kcal) would receive meals containing 0 g, 2.7 g, 5.4 g, and 10.8 g RS.
2 Energy and macronutrient values were determined using the USDA Nutrient Database for standard foods and from information supplied by the 
manufacturer for foods with added RS. Note that energy values calculated from the carbohydrate, fat, and protein content of study foods using the 
4-9-4 kcal/g factor method differ from reported energy values due to use of the Atwater system.Nutrition & Metabolism 2004, 1:8 http://www.nutritionandmetabolism.com/content/1/1/8
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before the addition of 100 µl 30% (v/v) hydrogen perox-
ide (for sample bleaching). Fat samples were counted in
Aquasol (Packard Bioscience, Groningen, Netherlands)
whereas breath samples were counted in Scintisafe 30%
(Fisher Chemical, New Jersey) using a Beckman LS6500
scintillation counter (Beckman Instuments, Fullerton,
CA). After scintillant was added, all samples were kept in
the dark at room temperature for 48 h before being
counted to reduce chemiluminescence.
Calculations
Calculation of total fat and carbohydrate oxidation
Formulae used to calculate non protein RQ and subse-
quent estimations of carbohydrate and fat oxidation were
based on the derivations described by Jéquier et al. ([39]).
Calculation of ∆RQ
∆RQ = RQt - RQbaseline
where t is sample time (min).
Calculation of meal fat storage from biopsy data
µg fat stored/g fat tissue = (dpm24h/g tissue weight) -
(dpmbaseline/g tissue weight) × 1/specific activity
µg fat stored/whole body = µg fat stored/g fat tissue × total
fat mass (from DEXA)
Calculation of 14C-triolein oxidation
counts from sample (dpm/mol CO2)/vCO2 (min.ml) =
(dpmt - dpmbackground) × 1/vCO2 =
dpm.mol CO2/ min.ml
dpm/min = dpm.mol CO2/ min.ml × 0.446 (as 1 ml CO2
= 0.446 mol)
g fat oxidized = AUC(dpm/min) × 1/specific activity
where vCO2 is the rate of CO2 production as assessed dur-
ing indirect calorimetry. t is sample time (min). AUC is
the incremental area under the curve.
Analysis
All statistical analyses were performed using the statistical
analysis software SAS, version 8.1 (SAS OnlineDoc, 2000)
with a significance level of p = 0.05 and p = 0.01 for inter-
action terms. All results are presented as mean ± SEM,
except for subject characteristics which are described as
mean ± SD. To investigate each of the outcomes (glucose,
insulin, FFA, TAG, RQ, meal fat oxidation, and meal fat
storage) we used a mixed model with fixed effect terms for
RS DOSE, TIME and the interaction of the two, RS
DOSE*TIME. Subjects were included as random effects.
The interaction term was not significant for any of the out-
comes tested so an additive model was used to test the
overall effect of RS DOSE and the differences between
doses. To test the effects of RS DOSE at different TIMES, a
model that included RS DOSE, TIME and RS DOSE*TIME
was used. The repeated measures nature of the study
design was taken into account by using the covariance
structures available in SAS PROC MIXED. For example,
measurements within a subject are assumed to be more
highly correlated than between subjects, and within a par-
ticular treatment, within a subject, the measurements are
assumed to be more correlated. Measurements closer in
time to one another were modeled with an autoregressive,
or AR(1) covariance structure.
Abbreviation List
RS, resistant starch; DS, digestible starch; TAG, triacylglyc-
erol; FFA, free fatty acid; FFM, fat free mass; SCFA, short-
chain fatty acids; GCRC, General Clinical Research Center;
RQ, respiratory quotient
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Additional File 1
Individual meal (a) and total fat oxidation (b) in response to the RS 
content of a test breakfast. Meal fat oxidation, assessed via measurement 
of 14CO2 in expired air, and total fat oxidation, assessed via indirect calor-
imetry and calculated from non-protein RQ, and was measured in 12 
healthy adults.
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